Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2026
Pyrophosphate Scintigraphy Changes After Tafamidis Therapy - Proposed Novel Index From Quantitative Single-Photon Emission Computed TomographyTsuneaki Yoshinaga, Shin Yanagisawa, Masatoshi Minamisawa, et al.Journal of Orthopaedic Surgery and Research|November 28, 2019
Clinical outcomes of treatment with locking compression plates for distal femoral fractures in a retrospective cohortMasahiro Kiyono, Tomoyuki Noda, Hiroshi Nagano, et al.BMC Nephrology|June 26, 2023
Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case reportYuki Shimamoto, Naoki Takahashi, Nagaaki Katoh, et al.Clinical Chemistry|January 18, 2014
Magnetically promoted rapid immunoreactions using functionalized fluorescent magnetic beads: a proof of principleSatoshi Sakamoto, Kenshi Omagari, Yoshinori Kita, et al.Developmental Cell|August 28, 2018
Combinatorial CRISPR/Cas9 Approach to Elucidate a Far-Upstream Enhancer Complex for Tissue-Specific Sox9 ExpressionYusuke Mochizuki, Tomoki Chiba, Kensuke Kataoka, et al.Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|April 13, 2026
Presence of lesser trochanter fragments is a risk factor for malrotation in subtrochanteric femoral fractures: A multicenter, retrospective, observational studyRyuichiro Okuda, Masanori Yorimitsu, Tomonori Tetsunaga, et al.Cancer Immunology, Immunotherapy : CII|November 5, 2020
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcomaYusuke Mochizuki, Hiroshi Tazawa, Koji Demiya, et al.Acta Medica Okayama|April 30, 2024
p53-Armed Oncolytic Virotherapy Improves Radiosensitivity in Soft-Tissue Sarcoma by Suppressing BCL-xL ExpressionTadashi Komatsubara, Hiroshi Tazawa, Joe Hasei, et al.Molecular Therapy. Oncology|August 7, 2024
p53-armed oncolytic virotherapy induces abscopal effect in osteosarcoma by promoting immunogenic cell deathKoji Demiya, Hiroshi Tazawa, Hiroya Kondo, et al.Anticancer Research|December 30, 2025
P53-Armed Oncolytic Virotherapy Promotes the Efficacy of PD1 Blockade in Murine Osteosarcoma TumorsMiho Kure, Hiroshi Tazawa, Koji Demiya, et al.Pageof 5